KCNIP3 and stroke disorder: In fact, DREAM increases its expression levels in several models of stroke, including primary hippocampal neurons after 3 h of oxygen–glucose deprivation (OGD) where it enhances the secretase-induced cleavage of Notch, contributing to cell death under ischemia-like conditions.